Prognostic value of HRD-RNA scores in patients with ovarian cancer

Positive HRD-RNA scores are associated with improved prognosis in ovarian cancer patients

INDICATION
Ovarian
BIOMARKER
HRD

Kaplan-Meier survival curves illustrate probability over time for four patient groups with differing outcomes.
Kaplan-Meier survival curves comparing rwOS in a group of patients with ovarian cancer stratified by Tempus HRD-RNA score and treatment with PARPi in 1L. Shaded areas represent the 95% confidence intervals. Median survival times (months) are specified. Log-Rank test P value is indicated.

 

Related cases

Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Abstract pixelated pattern of scattered colorful squares on a light gray grid background.

Characterizing B7-H4 co-expression and PD-L1 prevalence in platinum-resistant ovarian cancer

2026-07-01
Ovarian
PDL1
B7-H4
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Abstract pattern of light green squares forming a flowing, organic shape against a white background.

Integrating CA125 and ctDNA to enhance prognostic precision in ovarian cancer

2026-03-27
Ovarian
CA125
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
A grid displaying colored squares in purple, green, orange, and blue, possibly a data visualization.

Genomic profiling of HRD in soft tissue sarcomas

2025-10-09
Soft Tissue Sarcoma
HRD